Atorvastatin-induced severe thrombocytopenia

Lancet

Volumn 352, Issue 9136, 1998, Pages 1284-

  González Ponte, Maria Luisa ^b   González Ruiz, Mario ^a   Duvós, Elena ^b   Gutiérrez Iñiguez, Maria Angeles ^b   Olalla, Jose Ignacio ^b   Conde, Eulogio ^b  

^a Pharmacovigilance Regl Ctr of C   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CONSTIPATION; DYSPEPSIA; FLATULENCE; HEADACHE; HEMATOPOIESIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERURICEMIA; MALE; MYALGIA; PETECHIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0032541803     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70491-8     Document Type: Article

References (4)

1. 1 Anon. Atorvastatin: a new lipid-lowering agent. Med Lett 1997; 39: 29-31.
2. 2 Black DM, Bakker-Arkema RG, Nawrocki JW. An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor. Arch Intern Med 1998; 158: 577-84.
3. 3 Chong PH, Seeger JD. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors. Pharmacother 1997; 17: 1157-77.
4. 4 Pedersen-Bjergaad U, Andersen M, Hansen PB. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 1997; 52: 183-89.